7 JCI-accredited hospitals · 45+ hospitals & clinics · 90+ countries served · 24/7 multilingual support
Calculators| Second Opinion|| +90 535 876 04 89
Ask Aida
Prof. Ersin Özaslan, MD Medical Oncology · Acibadem Kayseri Hospital

Prof. Ersin Özaslan, MD

✓ Medically verified profile
Medical Oncology · Acibadem Kayseri Hospital

Prof. Ersin Özaslan, MD

Prof. Ersin Özaslan, MD is a medical oncologist in the Medical Oncology Department at Acibadem Kayseri Hospital in Kayseri, Turkey. He treats adults with solid tumors, including lung and thoracic cancers, colorectal cancer, breast cancer, bladder and prostate cancer, cervical and ovarian cancer, and stomach cancer. He consults in Turkish and English.

Medically verified profile 19+ years in medicineTurkish · EnglishVideo consultation available
Reach Dr. Özaslan → Consultation options
Free · a coordinator and the doctor’s team reply within 24 hours · no obligation
Prof. Ersin Özaslan, MDAccepting international patients
SpecialtyMedical Oncology
ConsultationVideo · In person · Second opinion
Profile

About Prof. Ersin Özaslan, MD

Prof. Ersin Özaslan, MD is a medical oncologist at Acibadem Kayseri Hospital in Kayseri, where he works in the Medical Oncology Department. He cares for adults with a range of solid tumors, including lung and other thoracic cancers, colorectal cancer, breast cancer, bladder and prostate cancer, cervical and ovarian cancer, and stomach cancer. He has more than 19 years in medicine and speaks Turkish and English.

Dr. Özaslan graduated from İstanbul University İstanbul Faculty of Medicine in 2007. He completed his training in Internal Medicine at Erciyes University Faculty of Medicine in 2012 and his training in Medical Oncology at the same faculty in 2016. From 2016 to 2018 he worked in Medical Oncology at Kayseri Training and Research Hospital, and in 2018 he joined Acıbadem Healthcare Services. He is a co-author of peer-reviewed publications on topics such as second- and third-line therapy in metastatic colorectal cancer, predictive markers in metastatic renal cell carcinoma, Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors, prognostic factors in breast cancer, and psychological distress in caregivers of advanced oncology inpatients. These articles appeared in journals including Journal of BUON, Journal of Chemotherapy, European Journal of Gastroenterology and Hepatology, Asian Pacific Journal of Cancer Prevention, Clinical Genitourinary Cancer and Journal of Health Psychology.

Clinical focus

Dr. Özaslan’s clinical work centers on the evaluation and medical treatment of solid tumors in adults. His areas of expertise include lung cancer and other thoracic cancers, as well as colorectal cancer, covering both colon cancer and rectal cancer. He also treats patients with breast cancer and with stomach cancer.

Within genitourinary oncology, his expertise covers bladder cancer and prostate cancer. In gynecological oncology, he sees patients with cervical cancer and ovarian cancer. In each case, the medical treatment plan is based on the individual diagnosis, disease stage and previous treatments, and is discussed with the patient after a review of the available findings.

How Dr. Özaslan works with international patients

Dr. Özaslan consults in Turkish and English, and interpreters can be arranged for patients who speak other languages. Before a visit, the international patient team coordinates the collection of prior medical reports and imaging, arranges appointments and organizes the hospital visit. A first consultation typically covers the patient’s history and symptoms, a review of existing imaging and previous treatments, a clinical examination and a discussion of the possible options. Video consultation is available for international patients who wish to discuss their case before traveling to Acibadem Kayseri Hospital, so that findings can be reviewed and further steps considered in advance.

Clinical focus

What Dr. Özaslan treats and performs

Each item opens the condition or treatment page with the care pathway for international patients.

Conditions treated

Procedures performed

Background

Education, career and memberships

Education & training

Education

  • 2016Erciyes University Faculty of Medicine Medical Oncology
  • 2012Erciyes University Faculty of Medicine Internal Medicine
  • 2007İstanbul University İstanbul Faculty of Medicine
Career

Professional Experience

  • 2018Acıbadem Healthcare Services
  • 2016–2018Kayseri Training and Research Hospital / Medical Oncology
Selected publications

Selected Publications

  • Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer Journal of BUON, 22(4), 863-868., (Control No: 3707902) (2017) ÖZASLAN ERSİN,TOPALOĞLU ULA? SERKAN,IMANÇ MEVLÜDE,ERDEM UMUT GÖKMEN,DEMİR HACER,ARPACI ERKAN,?EKER MEHMET METMET METİN,KARAAĞAÇ MUSTAFA,KIZILTEPE MELİH,EKER
  • Is sunitinib-induced hypothyroidism a predictive clinical marker for better response in metastatic renal cell carcinoma patients?. JOURNAL OF CHEMOTHERAPY, 28(3), 230-234., Doi: 10.1179/1973947815Y.0000000039., (Control No: 3714951) (2016) BOZKURT OKTAY,KARACA HALİT,HACIBEKİROĞLU İLHAN,KAPLAN MUHAMMED ALİ,DÜZKÖPRÜ YAKUP,UYSAL MÜKREMİN,BERK VELİ,İNANÇ MEVLÜDE,DURAN AY?E OCAK,ÖZASLAN ERSİN
  • Psychological distress and loneliness in caregiver of advanced oncological inpatients. Journal of Health Psychology, 21(9), 1896-1906., Doi: 10.1177/1359105314567770, (Control No: 3714548) (2016) SOYLU CEM,ÖZASLAN ERSİN,KARACA HALİT,ÖZKAN METİN
  • Evaluation of the concordance between the stage of the disease and Ki-67 proliferation index in gastroenteropancreatic neuroendocrine tumors. EUROPEAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 28(7), 836-841., Doi: 10.1097/MEG.0000000000000619., (2016) (Control No: 3708071) ÖZASLAN ERSİN,DEMİR SİNAN,KARACA HALİT,GÜVEN KADRİ
  • Hepatic steatosis is associated with higher incidence of liver metastasis in patients with metastatic breast cancer an observational clinical study JOURNAL OF BUON, 20(4), 963-969., (Control No: 3714005) (2015) DURAN AY?E OCAK,YILDIRIM AFRA,İNANÇ MEVLÜDE,KARACA HALİT,BERK VELİ,BOZKURT OKTAY,ÖZASLAN ERSİN,UÇAR MAHMUT,ÖZKAN METİN
  • Predictive Significance of VEGF and HIF-1? Expression in Patients with Metastatic Colorectal Cancer Receiving Chemotherapy Combinations with Bevacizum ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 16(14), 6149-6154., Doi: 10.7314/APJCP.2015.16.14.6149, (Control No: 3714044) (2015) BERK VELİ,DENİZ KEMAL,BOZKURT OKTAY,ÖZASLAN ERSİN,KARACA HALİT,İNANÇ MEVLÜDE,DURAN AY?E OCAK,ÖZKAN METİN
  • Predicting the role of the pretreatment neutrophil to lymphocyte ratio in the survival of early triple-negative breast cancer patients. JOURNAL OF BUON, 20(6), 1432-1439., (Control No: 3713937) (2015) BOZKURT OKTAY,KARACA HALİT,BERK VELİ,İNANÇ MEVLÜDE,DURAN AY?E OCAK,ÖZASLAN ERSİN,UÇAR MAHMUT,ÖZKAN METİN
  • Is Late Recurrence a Predictive Clinical Marker for Better Sunitinib Response in Metastatic Renal Cell Carcinoma Patients? CLINICAL GENITOURINARY CANCER, 13(6), 548-554., Doi: 10.1016/j.clgc.2015.07.005, (Control No: 3714914) (2015) BOZKURT OKTAY,HACIBEKİROĞLU İLHAN,KAPLAN MUHAMMED ALİ,DÜZKÖPRÜ YAKUP,UYSAL MÜKREMİN,KARACA HALİT,BERK VELİ,İNANÇ MEVLÜDE,DURAN AY?E OCAK,ÖZASLAN ERSİN
  • Positive effects of oral ?-glucan on mucocytis and leukopenia in colorectal cancer patients receiving adjuvant FOLFOX-4 combination chemotherapy ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 15(8), 3641-3644., Doi: 10.7314/APJCP.2014.15.8.3641, (Control No: 3714556) (2014) KARACA HALİT,BOZKURT OKTAY,ÖZASLAN ERSİN,BALDANE SÜLEYMAN,BERK VELİ,İNANÇ MEVLÜDE,DURAN AY?E OCAK,DİKİLTA? MUSTAFA,ER ÖZLEM,ÖZKAN METİN
  • Lack of prognostic value of mean corpuscular volume with capecitabine therapy in metastatic breast cancer ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 15(6), 2501-2504., Doi: 10.7314/APJCP.2014.15.6.2501, (Control No: 3714566) (2014) BOZKURT OKTAY,BERK VELİ,KAPLAN MUHAMMED ALİ,ÇETİN BÜLENT,ÖZASLAN ERSİN,KARACA HALİT,İNANÇ MEVLÜDE,DURAN AY?E OCAK,ÖZKAN METİN
Good to Know

Frequently Asked Questions

Which cancers does Dr. Özaslan treat?
Dr. Özaslan's areas of expertise include lung cancer and other thoracic cancers, colorectal cancer (colon and rectal cancer), breast cancer, bladder cancer, prostate cancer, cervical cancer, ovarian cancer and stomach cancer. As a medical oncologist, he focuses on the evaluation and medical treatment of these solid tumors in adults.
Where does Dr. Özaslan see patients?
He practices in the Medical Oncology Department at Acibadem Kayseri Hospital in Kayseri, Turkey. He joined Acıbadem Healthcare Services in 2018, after working in Medical Oncology at Kayseri Training and Research Hospital from 2016 to 2018.
What languages can I use when consulting Dr. Özaslan?
Dr. Özaslan consults in Turkish and English. For patients who speak other languages, interpreters can be arranged through the international patient team so that the consultation, the review of findings and the discussion of options can take place in a language the patient understands.
What should I send for a case review before my visit?
It is generally helpful to provide existing medical reports, pathology results, imaging studies with their written reports, and a summary of previous treatments. The international patient team coordinates the collection of these documents and arranges appointments, so that the first consultation can build on the information already available.
What is Dr. Özaslan's training background?
He graduated from İstanbul University İstanbul Faculty of Medicine in 2007, completed Internal Medicine training at Erciyes University Faculty of Medicine in 2012 and Medical Oncology training at the same faculty in 2016. He has more than 19 years in medicine and is a co-author of peer-reviewed oncology publications.
Can I have a video consultation with Dr. Özaslan before traveling?
Yes, video consultation is available for international patients. It can be used to discuss the diagnosis, review previously collected reports and imaging, and consider possible next steps before deciding whether to travel to Acibadem Kayseri Hospital for an in-person evaluation.
Where

Hospitals

Departments

Medical Units

Treatments

Treatment guides

Treatment
Bladder Cancer Treatment
Treatment
Breast Cancer Treatment
Treatment
Cervical Cancer Treatment
Treatment
Colon Cancer Treatment
Treatment
Lung Cancer Treatment
Treatment
Prostate Cancer Treatment
We’re With You at Every Step

How can we help you today?

Get a Second OpinionA second specialist team reviews your diagnosis and treatment plan. Start now Online Doctor ConsultationMeet an Acibadem specialist by secure video, before you travel. Book a video visit Ask AidaQuick, reliable answers from our medical team, in your language. Ask a question Free Medical ConsultationShare your case and receive a tailored plan and cost, free. Get started
We value your privacy We use essential cookies to run this site and, with your consent, analytics cookies to understand how it is used and improve it. You can accept, reject, or choose what to allow. See our Cookie Policy.